Bharat Biotech’s nasal vaccine, BBV154, has already completed Phase-2 trials with Covaxin. The proposed Ph-3 trials will cover those who have been administered with any two doses of the Covid-19 vaccine. Vaccine maker Bharat Biotech has sought regulatory nod to conduct Phase-3 trials of its nasal Covid-19 vaccine that can be used as a booster … Read more
An intranasal vaccine as a booster dose would be easier to administer in mass vaccination campaigns and has the potential to prevent transmission. Bharat Biotech has sought the Drug Controller General of India’s approval to conduct phase-3 trials of its COVID-19 intranasal vaccine (BBV154) to use as booster dose, sources said on Monday. “The application … Read more
The donation represents a gesture of goodwill to provide access to Bharat Biotech’s Covaxin to fight COVID- 19 pandemic across borders. The Republic of Vietnam will receive 2,00,000 doses of Bharat Biotech’s COVID-19 vaccine, a top official of the company said on Thursday. The announcement was made by Suchitra Ella, Joint Managing Director of Bharat … Read more
It was a matter of pride that the research and production of vaccines of two companies — Bharat Biotech and Zydus Cadila — took place in India, the minister said. Bharat Biotech on Sunday announced the commercial launch of the first batch of Covid-19 vaccine, Covaxin, from its Chiron Behring vaccine facility in Ankleshwar, Gujarat. … Read more
The reports had alleged that there were some irregularities associated with the hike in the vaccine price. In a surprising development, Hyderabad-based vaccine maker Bharat Biotech has cancelled the contract to supply its Coronavirus vaccine Covaxin to Brazil. The company in a statement issued on Friday said that it has terminated the contract to supply … Read more
Covaxin has not been granted permission to be used without restriction, even as Bharat Biotech had sought complete authorisation. Covaxin efficacy: Data from the phase 3 trials of Bharat Biotech’s Covaxin – India’s only indigenous coronavirus vaccine so far – has been shared by the manufacturer, and it shows that symptomatic COVID-19 cases can be … Read more
The DGCI had said that the decision to grant emergency approval to the vaccine maker was given on the basis of earlier phases of clinical trials. Bharat Biotech, the Hyderabad-based pharma major, has released the efficacy data of its Coronavirus vaccine ‘Covaxin’ on Wednesday. reported. According to news agency ANI, the company said that its … Read more
Soon after the company had been chosen by the DBT for the Rotavirus vaccine, the company shipped out the first batch of vaccine it had developed for Hepatitis B in the year 1999. (Credit: ANI) With the government regulator allowing the emergency use of the Covid-19 vaccine developed by Bharat Biotech, the Hyderabad-based company has … Read more
He also made it clear that the Covaxin vaccine will be administered to people under phase 3 trials and only after getting their prior consent. The Union Health Ministry has said that the centre and state governments were in a position to begin vaccination within 10 days of getting the approval from the regulator Drug … Read more
Coronavirus Covid 19 vaccine emergency use authorisation: (Reuters/Representational Photo) Covid-19 vaccine emergency use authorisation: The Ministry of Health and Family Welfare informed on Wednesday that the Subject Expert Committee (SEC) in Central Drugs Standard Control Organisation (CDSCO) held a meeting to consider the Emergency Use Authorisation (EUA) request of Pfizer, Serum Institute of India (SII) … Read more